Didem Torumkuney, PhD

Scientific Director
GSK
Brentford, England, United Kingdom

Disclosure(s): GSK: Employee, Stocks/Bonds (Public Company)

Presentation(s):

• 316 - In vitro Activity of Gepotidacin against Klebsiella pneumoniae, Including Molecularly Characterized ESBL and Carbapenemase positive Subsets Causing Urinary Tract Infections in the United States (2019-2022)

  Friday, October 18, 2024
  12:15 PM – 12:20 PM US PT